ABT in the 13F filings
Abbott Laboratories · CUSIP 002824100
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 8 Feb 2024
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 21 listed it in both
- Shares listed
- 190,830,660
- combined, among listed positions
- Reported value
- $21.0bn
- combined, at the quarter end
Among the 93 comparable managers: 13 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing ABT in Q4 2023
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Capital Research Global Investorsexisting position · 86,588,614 shares now+7,527,778
- Janus Henderson Group Ltdexisting position · 13,249,744 shares now+3,811,661
- Fidelity (FMR LLC)existing position · 7,605,149 shares now+1,521,106
- Wellington Management Group LLPexisting position · 32,236,101 shares now+1,027,390
- Arrowstreet Capital LPexisting position · 1,087,174 shares now+269,613
Reductions
- MFS Investment Managementexisting position · 12,053,028 shares now-1,543,960
- AllianceBernstein LPexisting position · 9,490,059 shares now-1,392,719
- AQR Capital Management LLCexisting position · 803,360 shares now-278,909
- Neuberger Berman Group LLCexisting position · 574,129 shares now-251,102
- Point72 Asset Management LPexisting position · 472,163 shares now-184,663
New positions and exits
New (1)
Exited (2)
- Element Capital Management LLCwas $14m
- Winton Group Ltdwas $4.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 21 | $3.5bn | n.a. | n.a. |
| Q3 2013 | 24 | $3.3bn | n.a. | n.a. |
| Q4 2013 | 21 | $4.0bn | n.a. | n.a. |
| Q1 2014 | 21 | $3.8bn | n.a. | n.a. |
| Q2 2014 | 29 | $4.9bn | n.a. | n.a. |
| Q3 2014 | 27 | $5.3bn | n.a. | n.a. |
| Q4 2014 | 25 | $5.9bn | n.a. | n.a. |
| Q1 2015 | 23 | $5.7bn | n.a. | n.a. |
| Q2 2015 | 25 | $6.5bn | n.a. | n.a. |
| Q3 2015 | 33 | $5.9bn | n.a. | n.a. |
| Q4 2015 | 24 | $6.5bn | n.a. | n.a. |
| Q1 2016 | 24 | $6.0bn | n.a. | n.a. |
| Q2 2016 | 27 | $5.7bn | n.a. | n.a. |
| Q3 2016 | 23 | $6.0bn | n.a. | n.a. |
| Q4 2016 | 25 | $5.5bn | n.a. | n.a. |
| Q1 2017 | 20 | $8.1bn | n.a. | n.a. |
| Q2 2017 | 17 | $10.5bn | n.a. | n.a. |
| Q3 2017 | 16 | $12.8bn | n.a. | n.a. |
| Q4 2017 | 19 | $14.8bn | n.a. | n.a. |
| Q1 2018 | 22 | $16.2bn | n.a. | n.a. |
| Q2 2018 | 17 | $16.9bn | n.a. | n.a. |
| Q3 2018 | 23 | $20.0bn | n.a. | n.a. |
| Q4 2018 | 19 | $20.1bn | n.a. | n.a. |
| Q1 2019 | 23 | $21.8bn | n.a. | n.a. |
| Q2 2019 | 18 | $22.5bn | n.a. | n.a. |
| Q3 2019 | 21 | $21.5bn | n.a. | n.a. |
| Q4 2019 | 21 | $22.4bn | n.a. | n.a. |
| Q1 2020 | 24 | $18.7bn | n.a. | n.a. |
| Q2 2020 | 27 | $20.7bn | n.a. | n.a. |
| Q3 2020 | 27 | $24.7bn | n.a. | n.a. |
| Q4 2020 | 29 | $24.8bn | n.a. | n.a. |
| Q1 2021 | 31 | $27.6bn | n.a. | n.a. |
| Q2 2021 | 29 | $26.5bn | n.a. | n.a. |
| Q3 2021 | 34 | $25.4bn | n.a. | n.a. |
| Q4 2021 | 28 | $29.2bn | n.a. | n.a. |
| Q1 2022 | 34 | $24.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $21.5bn | n.a. | n.a. |
| Q3 2022 | 30 | $18.8bn | n.a. | n.a. |
| Q4 2022 | 25 | $20.6bn | n.a. | n.a. |
| Q1 2023 | 32 | $19.2bn | n.a. | n.a. |
| Q2 2023 | 27 | $20.4bn | n.a. | n.a. |
| Q3 2023 | 30 | $17.7bn | n.a. | n.a. |
| Q4 2023 | 24 | $21.0bn | 13 | 12 |
| Q1 2024 | 27 | $20.6bn | 17 | 12 |
| Q2 2024 | 37 | $16.8bn | 23 | 13 |
| Q3 2024 | 28 | $17.7bn | 11 | 19 |
| Q4 2024 | 22 | $16.6bn | 9 | 11 |
| Q1 2025 | 28 | $20.9bn | 18 | 11 |
| Q2 2025 | 26 | $21.1bn | 14 | 13 |
| Q3 2025 | 20 | $21.3bn | 11 | 10 |
| Q4 2025 | 25 | $20.6bn | 18 | 18 |
| Q1 2026 | 35 | $19.1bn | 30 | 12 |
| Q2 2026 | 36 | $15.8bn | 23 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ABT and LLY →ABT and JNJ →ABT and VRTX →Choose a stock to compare with ABT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ABT, latest filings →Back to the 13F Explorer →